BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22108192)

  • 1. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
    Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming PLK1 inhibitor resistance by targeting mevalonate pathway to impair AXL-TWIST axis in colorectal cancer.
    Solanes-Casado S; Cebrián A; Rodríguez-Remírez M; Mahíllo I; García-García L; Río-Vilariño A; Baños N; de Cárcer G; Monfort-Vengut A; Castellano V; Fernández-Aceñero MJ; García-Foncillas J; Del Puerto-Nevado L
    Biomed Pharmacother; 2021 Dec; 144():112347. PubMed ID: 34700228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome activation is critical for cell death induced by inhibitors of polo-like kinase 1 (PLK1) in multiple cancers.
    Wang Y; Wang G; Xiang W; Liu X; Jiang M; Hu J
    Eur J Pharmacol; 2024 Jun; 972():176558. PubMed ID: 38614382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feed-forward activation of STAT3 signaling limits the efficacy of c-Met inhibitors in esophageal squamous cell carcinoma (ESCC) treatment.
    Zhao D; Chen J; Wang Y; Zhang L; Zhang J; Zhang W; Fan J; Li J; Zhan Q
    Mol Carcinog; 2021 Jul; 60(7):481-496. PubMed ID: 34018249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cyclooxygenase-2 on human esophageal squamous cell carcinoma.
    Zhang L; Wu YD; Li P; Tu J; Niu YL; Xu CM; Zhang ST
    World J Gastroenterol; 2011 Nov; 17(41):4572-80. PubMed ID: 22147962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3-EphA7 axis contributes to the progression of esophageal squamous cell carcinoma.
    Wang L; Zhao QF; Yang BB; Liang HJ; Zhang XE; Zhang XY; Yang WJ; Guo ZY; Xu X; Tian F; Wu QH
    Acta Oncol; 2023 Dec; 62(12):1757-1766. PubMed ID: 37738252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonpeptidic, Polo-Box Domain-Targeted Inhibitors of PLK1 Block Kinase Activity, Induce Its Degradation and Target-Resistant Cells.
    Chapagai D; Ramamoorthy G; Varghese J; Nurmemmedov E; McInnes C; Wyatt MD
    J Med Chem; 2021 Jul; 64(14):9916-9925. PubMed ID: 34210138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polo-like-kinase 1 is a proviral host factor for hepatitis B virus replication.
    Diab A; Foca A; Fusil F; Lahlali T; Jalaguier P; Amirache F; N'Guyen L; Isorce N; Cosset FL; Zoulim F; Andrisani O; Durantel D
    Hepatology; 2017 Dec; 66(6):1750-1765. PubMed ID: 28445592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofilament heavy polypeptide regulates the Akt-beta-catenin pathway in human esophageal squamous cell carcinoma.
    Kim MS; Chang X; LeBron C; Nagpal JK; Lee J; Huang Y; Yamashita K; Trink B; Ratovitski EA; Sidransky D
    PLoS One; 2010 Feb; 5(2):e9003. PubMed ID: 20140245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLK1 regulating chemoradiotherapy sensitivity of esophageal squamous cell carcinoma through pentose phosphate pathway/ferroptosis.
    Zhao M; Lu T; Bi G; Hu Z; Liang J; Bian Y; Feng M; Zhan C
    Biomed Pharmacother; 2023 Dec; 168():115711. PubMed ID: 37879213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice.
    Chen ZH; Yu YP; Tao J; Liu S; Tseng G; Nalesnik M; Hamilton R; Bhargava R; Nelson JB; Pennathur A; Monga SP; Luketich JD; Michalopoulos GK; Luo JH
    Gastroenterology; 2017 Oct; 153(4):1120-1132.e15. PubMed ID: 28245430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis.
    Deeraksa A; Pan J; Sha Y; Liu XD; Eissa NT; Lin SH; Yu-Lee LY
    Oncogene; 2013 Jun; 32(24):2973-83. PubMed ID: 22890325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plk1 phosphorylation of Numb leads to impaired DNA damage response.
    Shao C; Chien SJ; Farah E; Li Z; Ahmad N; Liu X
    Oncogene; 2018 Feb; 37(6):810-820. PubMed ID: 29059161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic targeting of the PLK1-PRC1-axis triggers cell death in genomically silent childhood cancer.
    Li J; Ohmura S; Marchetto A; Orth MF; Imle R; Dallmayer M; Musa J; Knott MML; Hölting TLB; Stein S; Funk CM; Sastre A; Alonso J; Bestvater F; Kasan M; Romero-Pérez L; Hartmann W; Ranft A; Banito A; Dirksen U; Kirchner T; Cidre-Aranaz F; Grünewald TGP
    Nat Commun; 2021 Sep; 12(1):5356. PubMed ID: 34531368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cucurbitacin B Inhibits the Malignancy of Esophageal Carcinoma through the KIF20A/JAK/STAT3 Signaling Pathway.
    Liu C; Ji J; Li C
    Am J Chin Med; 2024; 52(1):275-289. PubMed ID: 38291583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deguelin, an Aurora B Kinase Inhibitor, Exhibits Potent Anti-Tumor Effect in Human Esophageal Squamous Cell Carcinoma.
    Yu X; Liang Q; Liu W; Zhou L; Li W; Liu H
    EBioMedicine; 2017 Dec; 26():100-111. PubMed ID: 29129699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLK1 Induces Chromosomal Instability and Overrides Cell-Cycle Checkpoints to Drive Tumorigenesis.
    Gheghiani L; Wang L; Zhang Y; Moore XTR; Zhang J; Smith SC; Tian Y; Wang L; Turner K; Jackson-Cook CK; Mukhopadhyay ND; Fu Z
    Cancer Res; 2021 Mar; 81(5):1293-1307. PubMed ID: 33376114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLK1 and FoxM1 expressions positively correlate in papillary thyroid carcinoma and their combined inhibition results in synergistic anti-tumor effects.
    Poyil PK; Siraj AK; Padmaja D; Parvathareddy SK; Thangavel S; Alobaisi K; Diaz R; Begum R; Haqawi W; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
    Mol Oncol; 2024 Mar; 18(3):691-706. PubMed ID: 38361222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 10,11-dehydrocurvularin exerts antitumor effect against human breast cancer by suppressing STAT3 activation.
    Zhao Q; Bi Y; Zhong J; Li X; Guo J; Liu YX; Pan LR; Tan Y; Deng ZS; Yu XJ
    Acta Pharmacol Sin; 2021 May; 42(5):791-800. PubMed ID: 32868906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plk1 overexpression induces chromosomal instability and suppresses tumor development.
    de Cárcer G; Venkateswaran SV; Salgueiro L; El Bakkali A; Somogyi K; Rowald K; Montañés P; Sanclemente M; Escobar B; de Martino A; McGranahan N; Malumbres M; Sotillo R
    Nat Commun; 2018 Aug; 9(1):3012. PubMed ID: 30069007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.